Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026)

Amphastar Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$6.2 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 120.08% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$16.3 million, a 123.31% decrease from a year earlier, with the FY2025 full-year figure at $21.1 million, down 56.84% from the prior year.
• Change in Inventory improved to -$6.2 million in Q1 2026 per AMPH's latest filing, from -$9.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $31.1 million in Q1 2025 and bottomed at -$9.0 million in Q4 2025.
• The 5-year median for Change in Inventory is $4.7 million (2022), against an average of $4.5 million.
• Across the five-year window, Change in Inventory tumbled 309.27% in 2023 and soared 3829.48% in 2024, its largest moves.
• Year by year, Change in Inventory stood at -$1.2 million in 2022, then sank by 309.27% to -$4.8 million in 2023, then surged by 608.37% to $24.5 million in 2024, then slumped by 136.82% to -$9.0 million in 2025, then surged by 30.65% to -$6.2 million in 2026.
• Per Business Quant, the three latest AMPH Change in Inventory figures stand at -$6.2 million (Q1 2026), -$9.0 million (Q4 2025), and -$5.9 million (Q3 2025).